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SLEEP DISTURBANCES AND THE AT RISK MENTAL STATE: A 1 
SYSTEMATIC REVIEW AND META-ANALYSIS 2 
ABSTRACT 3 
Aims: To synthesise and investigate how sleep disturbances relate to psychotic 4 
symptoms, functioning and Quality of Life (QoL) in At Risk Mental State (ARMS) 5 
youth. 6 
Method: A comprehensive search of six databases (MEDLINE, PsycINFO, Embase, 7 
CINAHL, Web of Science and CENTRAL) was conducted. Eligible studies provided 8 
data on sleep disturbances or disorders in ARMS patients.  9 
Results: Sixteen studies met the inclusion criteria (n=1962 ARMS patients) including 10 
7 cross-sectional studies, 2 RCT’s and 7 cohort studies.Narrative synthesis revealed 11 
that self-reported sleep (e.g., general disturbances, fragmented night time sleep and 12 
nightmares) was poorer among ARMS patients compared to healthy controls. In the 13 
limited studies (n=4) including objective measurements of sleep disturbances, ARMS 14 
patients experienced higher levels of movement during sleep, more daytime naps 15 
and increased sleep latency compared to controls.  Furthermore, sleep disturbances 16 
were associated with attenuated psychotic symptoms and functional outcomes 17 
cross-sectionally and longitudinally. Only one study investigated the relationship 18 
between sleep and QoL. The exploratory meta-analysis revealed a significant 19 
difference in self-reported sleep disturbances measured by the PSQI (mean 20 
difference in score: 3.30 (95% CI 1.87, 4.74), p<0.00001) and SIPS (mean difference 21 
in score: 1.58 (95% CI 0.80, 2.35), p<0.00001) of ARMS patients compared to 22 
control groups. 23 
 24 
Conclusions: ARMS individuals report impaired sleep quality and reduced sleep 25 
quantity compared to healthy controls. However, further research is needed to 26 
explore the longitudinal relationship between sleep disruptions and QoL in early 27 
psychosis. Significant variations in how sleep is measured across studies highlights 28 
a need to assess disturbances to sleep using robust and consistent approaches in 29 
this patient group.  30 
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1 INTRODUCTION 34 
Sleep is a fundamental biological need that is commonly disrupted in individuals that 35 
experience psychosis (Freeman et al., 2015; Kaskie et al., 2017; Rowland and 36 
Wickwire, 2018). Research has shown that disturbances to sleep occur early in the 37 
course of psychotic illness, often pre-diagnosis, and persist throughout the course of 38 
the disorder (Cohrs, 2008; Yung and McGorry, 1996a). Although prevalence rates 39 
are difficult to determine, one study reported that 21-100% of individuals experience 40 
difficulties with their sleep in the early stages of psychosis, whilst another study 41 
reported 77-100% of sleep disturbances present  before the first episode of 42 
psychosis (Tan and Ang, 2001; Yung and McGorry, 1996b). Both the widespread 43 
nature of sleep disturbances and the early presence of sleep problems in psychosis 44 
including the prodrome period suggests that they are not necessarily a consequence 45 
of disease chronicity or medication status (Keshavan et al., 2011b; Yung and 46 
McGorry, 1996b). Instead, sleep disruptions may be an indicator, or in some cases a 47 
marker, of impending deteriorations to mental health and possibly transition to 48 
psychosis (Poulin et al., 2008; Zanini et al., 2013).  However, the characteristics of 49 
sleep that are indicative of poorer mental health outcomes prior to a diagnosis of 50 
psychosis remain unclear, particularly in individuals who may be at risk of developing 51 
psychosis such as those with an identified at risk mental state (ARMS). 52 
Research has suggested that sleep disruptions and functional impairments share a 53 
number of key features in ARMS patients; they are often reported prior to diagnosis, 54 
are persistent and linked to transition to psychosis (Rapado-Castro et al., 2015; 55 
Robustelli et al., 2017; Velthorst et al., 2013). Furthermore, functional deficits are 56 
important for ARMS youth who transition to psychosis and those who do not; as they 57 
correlate with neurocognitive impairments, negative symptoms and disorganised 58 
behaviour (Cotter et al., 2014; Lin et al., 2011). A link between functional outcomes 59 
and sleep has been documented in healthy and clinical populations, with poor sleep 60 
impacting on daytime functioning and cognitive processes (Anderson and Bradley, 61 
2013). However, little is known about the relationship between sleep disruptions and 62 
functional outcomes in ARMS youth, although both may present as a risk factor for 63 
poorer long-term clinical outcomes (Alderman et al., 2015; Fusar-Poli et al., 2017).  64 
The relationship between disturbed sleep and Quality of Life (QoL) is also an 65 
important line of enquiry; as the prevalence and impact of reduced QoL is well 66 
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documented in ARMS groups (Fusar-Poli et al., 2015; Ohmuro et al., 2017; 67 
Ruhrmann et al., 2008). Furthermore, poor sleep has been implicated in the 68 
sustainment of decreased QoL in patients diagnosed with psychotic illness (Afonso 69 
et al., 2011; Hofstetter et al., 2005; Ritsner et al., 2004). This relationship can be 70 
explained by the distress/protection vulnerability model of QoL which suggests that 71 
sleep is a protective factor, but if impaired can be distressing resulting in reduced 72 
QoL (Felce and Perry, 1995; Ritsner et al., 2004). Consequently, it is important to 73 
clarify the nature of the relationship between sleep and QoL prior to a diagnosis of 74 
psychosis, as sleep difficulties may represent a target for interventions aimed at 75 
improving QoL in ARMS youth. 76 
Several systematic reviews have thoroughly examined the relationship between 77 
sleep disruptions and psychotic symptoms and illness (Davies et al., 2017; Lunsford-78 
Avery and Mittal, 2013; Reeve et al., 2015; Waite et al., 2019; Zanini et al., 2013). A 79 
recent high quality review reported on the nature of sleep disruptions in ARMS and 80 
First Episode Psychosis (FEP) samples (Davies et al., 2017). There have since been 81 
a number of new studies published in this area. Therefore, this review will update 82 
and extend current knowledge on self-reported and objective measurements of sleep 83 
disturbances and how they interact with attenuated psychotic symptoms, patient QoL 84 
and functional outcomes in ARMS youth. We will conduct an exploratory meta-85 
analysis to quantitatively assess the magnitude of self-reported general sleep 86 
disturbance in ARMS groups, which to our knowledge has not been carried out 87 
before.  88 
The two key aims of this paper are to (i) characterise self-reported and objectively 89 
measured sleep disturbances during the ARMS period and to (ii) examine cross-90 
sectional and longitudinal relationships between sleep disturbances and psychotic 91 
symptoms, functioning and QoL in ARMS patients.  92 
93 
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2 METHOD 94 
This review was carried out in line with the Preferred Reporting Items for Systematic 95 
Reviews and Meta-Analyses (PRISMA) statement. The protocol is registered on 96 
PROSPERO (CRD42017069160). 97 
2.1 Data sources and search strategy 98 
We conducted electronic searches of the following databases: MEDLINE, Embase, 99 
CINAHL, PsycINFO, Web of Science and Cochrane Central Register of Controlled 100 
Trials (CENTRAL). The reference lists of eligible studies were hand searched to 101 
identify further relevant studies. Grey literature including doctoral thesis and 102 
conference abstracts were screened for eligibility to reduce the risk of publication 103 
bias. No date or publication status restrictions were applied during the searches. 104 
Non-English language studies were excluded due to limited resources.  105 
 106 
We performed all searches on 10th July and re-ran searches on 14th February 2020. 107 
Search terms were developed with advice from a medical librarian and field experts. 108 
A combination of risk terms (e.g. “ultra high risk”), psychosis terms (e.g. ‘psycho*) 109 
and sleep terms (e.g. ‘insomnia’) were used in electronic searches (see appendix A).  110 
2.2 Eligibility criteria  111 
Eligible studies included at least ≥50% of participants (aged 12-35 years old) 112 
assessed to be Ultra High Risk as identified by any standardised measure of At Risk 113 
Mental State (including the Comprehensive Assessment of the At Risk Mental State 114 
(CAARMS) (Yung et al., 2005); The Structured Interview for Psychosis-Risk 115 
Syndromes (SIPS); the Structured Clinical Interview for DSM Disorders (SCID) 116 
(Lobbestael et al., 2011)). Studies that did not involve UHR participants or did not 117 
include a formal assessment of the At Risk Mental State (ARMS) were excluded.  118 
 119 
All studies reported objective measurements (e.g. actigraphy which is a non-intrusive 120 
device worn to monitor and record movement/activity levels or polysomnography 121 
which is the gold standard assessment of sleep involving EEG and monitoring of 122 
heart rate, breathing, movement and oxygen levels) or self-reported data (e.g. 123 
validated self-reported measures, sleep diaries) on sleep or sleep related outcomes 124 
6 
 
(e.g. chronotype and daytime sleepiness).  Studies not reporting sleep outcomes, 125 
disturbances or sleep disorders using validated tools were excluded. 126 
 127 
Randomised, non-randomised trials and observational studies (cross sectional and 128 
prospective) were included in this review. However, case control studies involving 129 
<20 ARMS participants were excluded.  Unpublished studies and meeting abstracts 130 
were screened but did not meet the inclusion criteria.  Non English studies were 131 
excluded. 132 
2.3 Screening procedure 133 
Search results were imported into reference manager software (endnote) and 134 
duplicates removed. One reviewer (LC) screened all titles and abstracts and another 135 
member of the team (FE) screened a random 20% of articles. LC and FE 136 
independently screened 100% of full text articles; all disagreements were resolved 137 
by discussion with a third party (AT).  138 
2.4 Quality assessment and risk of bias 139 
The quality of studies was assessed using the Downs and Black quality index tool 140 
(Downs and Black, 1998). This is a 27-item checklist for measuring quality with high 141 
criterion validity (r=0.90), internal consistency reliability (Cronbach alpha >0.69) and 142 
external validity (Cronbach alpha= 0.54).  The tool has high test-retest reliability 143 
scores for both randomised and non-randomised studies (r: 0.69-0.90) (Downs and 144 
Black, 1998). The levels of categories for quality are: excellent (26-28), good (20-25), 145 
fair (15-19) and poor (≤14) (Jutai et al., 2009). 146 
2.5 Data extraction 147 
Details of eligible studies were recorded using pre-piloted data collection forms. 148 
Author details, study details (including year of study, country of study, number and 149 
duration of follow up assessments), participant information (including number of 150 
participants/age/gender), assessment tools used to assess ARMS/sleep/functioning 151 
and QoL and were collected for each study. 152 
2.6 Data synthesis and analysis 153 
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A narrative synthesis approach (Popay et al., 2006) was adopted for the analysis of 154 
studies included in this review. Exploratory meta-analysis was not possible for all 155 
included studies due to the heterogeneity of data. Consequently, three studies 156 
reporting means and standard deviations from the Structured Interview for Prodromal 157 
Symptoms (SIPS) and two studies reporting means and standard deviations from the 158 
Pittsburgh Sleep Quality Index (PSQI) were pooled in two separate exploratory 159 
meta-analyses.  160 
Random effects models (Revman version 5.3) were used for the quantitative 161 
synthesis of comparable data which did not involve overlapping samples. 162 
Heterogeneity of studies was examined using the I2 statistic.   163 
164 
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3 RESULTS 165 
3.1 Search yield 166 
Database searches and retrieval from other sources revealed 7825 articles; following 167 
the removal of duplicates 6585 papers were left of which 6451 were excluded at title 168 
and abstract stage. The remaining 134 articles were assessed at full text level for 169 
eligibility. Full text agreement between reviewers was high (k =0.8). One hundred 170 
and eighteen papers were excluded following full text review. Sixteen studies 171 
provided data on sleep in ARMS samples and were included in the final review (see 172 
Figure 1).  173 
 174 
 175 
 176 
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. 197 
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3.2 Study and participant characteristics  198 
The included studies involved 1962 at risk participants from the USA and Canada 199 
(n=1459), Europe (n= 601), Brazil (n=20) and Australia (n=10). Study designs varied 200 
and included seven cross-sectional studies, seven cohort studies and two RCT’s 201 
(see table 1).  Follow up periods for longitudinal studies ranged from 1 to 8.9 years 202 
and outcomes were based on psychotic symptoms, conversion to psychosis and 203 
psychosocial functioning. Six studies did not include a control group, however those 204 
who did (n= 10) (Castro et al., 2015; Goines et al., 2019; Lederman et al., 2017; 205 
Lindgren et al., 2017b; Lunsford-Avery et al., 2017b; Lunsford-Avery et al., 2015; 206 
Lunsford-Avery et al., 2013; Michels et al., 2014; Tso et al., 2017; Zanini et al., 2015) 207 
included a wide spectrum of participants including: Healthy Controls (HC), healthy 208 
relatives, First Episode Psychosis (FEP) patients, and individuals diagnosed with 209 
psychotic disorder (see table 1).  210 
 211 
Four studies were produced by the Adolescent Development and Prevention 212 
Treatment lab at the University of Colorado Boulder  (Lunsford-Avery et al., 2017a; 213 
Lunsford-Avery et al., 2017b; Lunsford-Avery et al., 2015; Lunsford-Avery et al., 214 
2013) and two studies from The Program for Recognition and Intervention in 215 
Individuals at-risk Mental State (Castro et al., 2015; Zanini et al., 2015). Despite the 216 
overlap in samples, these studies were included in the review due to the reporting of 217 
different sleep outcomes. However, these studies were not compared directly in the 218 
exploratory meta-analysis to prevent inflation of the reported effect sizes (Higgins 219 
and Altman, 2008). Only studies including comparable data without overlapping 220 
samples were compared in the meta-analysis.  221 
3.3 Sleep related outcomes 222 
Sleep was measured using a range of self-reported measures including the 223 
Pittsburgh Sleep Quality Index (n=6), Epworth Sleepiness Scale (n=2), 224 
Questionnaire of Morningness and Eveningness (n=2), the Structured Interview for 225 
Prodromal Symptoms (SIPS) (n=7), lucid dream and nightmare frequency scales 226 
(n=1), the Economic Patient Questionnaire Interview (n=1); and objective measures 227 
including actigraphy (n=3) and polysomnography (n=1). The duration of monitoring 228 
for actigraphy varied between five (Lunsford-Avery et al., 2017b; Lunsford-Avery et 229 
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al., 2015) and fifteen consecutive days (Castro et al., 2015) and PSG was two 230 
consecutive nights (Zanini et al., 2015). The reporting of the sleep data varied, for 231 
instance some articles included dichotomous outcomes (e.g. poor sleeper and good 232 
sleeper) (Lunsford-Avery et al., 2017a; Miller et al., 2003b) and/or continuous 233 
outcomes (e.g. means and standard deviations) (Castro et al., 2015; Grivel et al., 234 
2018; Lederman et al., 2017; Lindgren et al., 2017b; Lunsford-Avery et al., 2017b; 235 
Lunsford-Avery et al., 2015; Lunsford-Avery et al., 2013; Michels et al., 2014; Poe et 236 
al., 2017; Ruhrmann et al., 2010; Tso et al., 2017; Zanini et al., 2015).  237 
4 MAIN RESULTS 238 
 239 
4.1 Self-report and objective sleep disturbances in ARMS patients  240 
4.1.1 Latency 241 
Three studies reported sleep latency scores (defined as the amount of time taken to 242 
transition from wakefulness into a state of sleep, see table 2) (Lederman et al., 2017; 243 
Lunsford-Avery et al., 2013; Zanini et al., 2013). PSG and PSQI sleep latency scores 244 
were significantly higher in ARMS compared to HC’s (Lunsford-Avery et al., 2015; 245 
Zanini et al., 2015).  In contrast, Lederman et al. (2017) found no significant 246 
difference in the PSQI sleep latency scores of HC’s, ARMS and FEP patients.  247 
4.1.2 Efficiency  248 
Four studies presented sleep efficiency findings (defined as the ratio of total sleep 249 
time to time spent in bed) (Lederman et al., 2017; Lunsford-Avery et al., 2015; 250 
Lunsford-Avery et al., 2013; Zanini et al., 2015). There were no significant 251 
differences in the PSG efficiency percentages or PSQI efficiency scores of ARMS 252 
compared to HC’s. However, one study reported significantly reduced actigraphic 253 
measured sleep efficiency in an ARMS group (Lunsford-Avery et al., 2015). 254 
Furthermore, there was an association at trend level between PSQI efficiency and 255 
actigraphy efficiency scores among ARMS youth but not HC’s (Lunsford-Avery et al., 256 
2015).  257 
4.1.3 WASO 258 
Two studies reported Wake After Sleep Onset (WASO) (defined as the time spent 259 
awake after sleep onset) results (Lunsford-Avery et al., 2015; Zanini et al., 2015). In 260 
the first study, actigraphy WASO scores of ARMS were found to be significantly 261 
higher than HC youth (Lunsford-Avery et al., 2015). However, Zanini et al. (2015) 262 
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reported no significant difference in the PSG WASO scores of ARMS participants 263 
compared to HC counterparts. 264 
4.1.4 Night time awakenings 265 
Three studies reported on nightmare awakenings (Lederman et al., 2017; Lunsford-266 
Avery et al., 2015; Lunsford-Avery et al., 2013). Findings from these studies revealed 267 
no significant differences in the mean actigraphy or self-reported PSQI scores for 268 
ARMS compared to HC participants (Lederman et al., 2017; Lunsford-Avery et al., 269 
2015). Furthermore, no significant associations were revealed between self-reported 270 
(PSQI) and objectively measured (actigraphy) night time awakenings in ARMS or HC 271 
participants (Lunsford-Avery et al., 2015).  Lunsford-Avery et al. (2013) reported that 272 
the ARMS group endorsed significantly more disturbances than HC’s according to 273 
the PSQI disturbance subscale.  274 
4.1.5 Total Sleep Time 275 
Four studies provided data on Total Sleep Time (TST) (Lederman et al., 2017; 276 
Lunsford-Avery et al., 2015; Lunsford-Avery et al., 2013; Zanini et al., 2015). 277 
Polysomnographic and actigraphic TST scores were not found to be significantly 278 
different between ARMS and HC groups (Lunsford-Avery et al., 2015; Zanini et al., 279 
2015). Similarly, there were no between group differences in PSQI sleep duration 280 
scores (Lederman et al., 2017; Lunsford-Avery et al., 2013). Interestingly, Lunsford-281 
Avery et al. (2015) reported a significant relationship between PSQI sleep duration 282 
and actigraphy TST in both ARMS and HC participants (Lunsford-Avery et al., 2015).  283 
4.1.6 Movements 284 
One study reported actigraphy measured night time movements to be significantly 285 
increased in ARMS patients compared to HC (Lunsford-Avery et al., 2015). 286 
4.1.7 Day time naps 287 
In addition to impaired night time sleep, ARMS individuals endorsed significantly 288 
longer naps compared to HC’s according to actigraphic data (Castro et al., 2015).   289 
4.1.8 General sleep disturbance  290 
Six studies presented findings on self-reported sleep disturbances (Grivel et al., 291 
2018; Lederman et al., 2017; Miller et al., 2003b; Poe et al., 2017; Tso et al., 2017; 292 
Zanini et al., 2015). Tso et al. (2017) revealed that clinically higher risk patients 293 
(global score ≥ 7 on the SOPS) experienced greater levels of sleep disturbance 294 
compared to clinically lower risk patients (global score < 7 on the SOPS) according 295 
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to the SOPS.  Grivel et al. (2018) also reported that ARMS patients with any lifetime 296 
trauma endorsed higher SIPS sleep disturbance scores compared to those with no 297 
trauma. A further study assessing sleep disturbances using the SIPS revealed one 298 
third (37%) of ARMS patients scored between 3 (moderate) and 6 (extreme) on the 299 
sleep disturbance SIPS subscale (Miller et al., 2003b). A final study reported a 300 
significant difference in scores between ARMS and HC’s on the SIPS G1 subscale 301 
(Poe et al., 2017). There are seven items assessing sleep disturbances on the 302 
SIPS/SOPS; with higher scores suggesting higher levels of disturbed sleep (Miller et 303 
al., 2003a). 304 
Zanini et al. (2015) revealed that 75% of ARMS patients and only 30% of HC’s 305 
scored greater than 5 on the PSQI measure. In addition, another study reported the 306 
ARMS group (mean score 8.0, SD 3.3) PSQI mean score to be significantly higher 307 
than the HC group mean (mean score 3.9, SD 1.5) (Lederman et al., 2017). A global 308 
score of <5 indicates “good” sleep quality commonly reported amongst healthy 309 
control subjects in comparison to a score >5 on the PSQI that is suggestive of “poor” 310 
sleep often observed in clinical samples (Buysse et al., 1989).  311 
4.1.9 Daytime sleepiness 312 
Three studies provided findings on daytime sleepiness (Lederman et al., 2017; Poe 313 
et al., 2017; Zanini et al., 2015). ARMS participants endorsed significantly higher 314 
SIPS measured daytime fatigue (Poe et al., 2017) and PSQI daytime dysfunction 315 
compared to HC’s (Lederman et al., 2017). Conversely, daytime sleepiness scores 316 
derived from the Epworth Sleepiness Scale were not significantly different between 317 
ARMS and HC’s (Zanini et al., 2015).  318 
4.1.10 Dreaming and Parasomnia 319 
One study reported on dreaming and nightmares using the Lucid dream and 320 
nightmare frequency scales, revealing that ARMS patients reported a significantly 321 
higher frequency of nightmares compared to HC’s (Michels et al., 2014). Dream 322 
recall frequency was also found to be highest among ARMS patients compared to 323 
healthy controls(Michels et al., 2014).  324 
4.1.11 Circadian rhythm  325 
Four studies reported on circadian rhythm (defined as the internal biological rhythms 326 
that that coordinate behavioural and physical activity with the environment during a 327 
24h period) (Castro et al., 2015; Lunsford-Avery et al., 2015; Poe et al., 2017; Zanini 328 
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et al., 2015). Castro et al. (2015) revealed between group differences in the 329 
actigraphic autocorrelation function parameter, which is an indicator of circadian 330 
rhythm fragmentation; values closer to zero suggest a less fragmented rhythm. 331 
ARMS participants (mean score: -0.14.SD 0.03) experienced more fragmentation 332 
compared to healthy controls (mean score: -0.11. SD 0.02). However, Lunsford-333 
Avery et al. (2015) did not find this parameter to be significantly different among 334 
ARMS (mean score: 20.67. SD 8.37) and HC’s (mean score: 20.63. SD 5.42). 335 
Participants wore actigraphs for five days in the Lunsford-Avery et al. (2015) study 336 
compared to 15 consecutive days in the Castro et al. (2015) study. In a further study, 337 
ARMS participants reported increased sleep pattern disruption (17.5% of ARMS 338 
youth vs 0% HC) and day/night reversal (11.9% of ARMS youth vs 0% HC) as 339 
measured by the SIPS (Poe et al., 2017). 340 
 341 
4.2 Cross-sectional associations between sleep disturbances, psychotic 342 
symptoms, functioning and QoL 343 
4.2.1 Sleep and positive symptoms 344 
A total of five studies reported cross-sectional associations between sleep 345 
disturbances and positive symptoms (Goines et al., 2019; Lunsford-Avery et al., 346 
2015; Lunsford-Avery et al., 2013; Poe et al., 2017). In one study, SIPS rated sleep 347 
disturbances were found to be significantly associated with severity of total positive 348 
symptoms (p < 0.01) in a large sample of 740 ARMS youth (Goines et al., 2019). 349 
These self-reported sleep disruptions were found to relate to the severity of specific 350 
attenuated psychotic symptoms; suspiciousness (p = 0.006) and perceptual 351 
abnormalities (p = 0.001). When exploring mediation effects, the researchers 352 
revealed that depression held an indirect effect on the relationship between sleep 353 
disturbance and persecutory symptoms (b = 0.0537, CI (95%) = 0.0319–0.0787) but 354 
the same was not true for perceptual abnormalities or disorganised communication. 355 
Similarly, in a large help seeking sample of 194 ARMS patients, SIPS rated sleep 356 
pattern disruption (B=3.37, p= < 0.01 ) and day night reversal (B=3.05, p= < 0.01 ) 357 
were found to be significantly related to positive psychotic symptoms (Poe et al., 358 
2017). Lunsford-Avery et al. (2015) reported several actigraphic sleep parameters to 359 
be associated with baseline positive symptoms including reduced sleep efficiency (F 360 
(3, 31) = 8.19, p < .01), increased WASO (F (3, 31) = 12.50, p < .01), greater 361 
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numbers of night time awakenings (F (3, 31) = 2.81, p = .05) and increased 362 
movements (F (3, 31) = 7.26, p < .01) among ARMS and HC participants.  363 
Interestingly, TST scores were not associated with positive symptoms (p=0.37). In a 364 
study involving an overlapping sample, several circadian rhythm parameters were 365 
found to correlate with baseline positive symptoms severity (Lunsford-Avery et al., 366 
2013). These included lower autocorrelation function (p<0.05), lower diurnal activity 367 
(p<0.05) and increased intradaily variability (an indication of rest activity 368 
fragmentation) (p<0.05). However, self-reported PSQI scores were not found to be 369 
associated with SIPS positive symptoms in ARMS participants. 370 
4.2.2 Sleep and negative symptoms 371 
Three studies reported on the relationship between sleep disturbances and negative 372 
symptoms (Lunsford-Avery et al., 2017a; Lunsford-Avery et al., 2013; Poe et al., 373 
2017). Negative symptom levels measured by the SIPS were found to be related to 374 
decreased sleep duration, increased sleep latency and reduced sleep quality in 375 
ARMS patients (Lunsford-Avery et al., 2013). Furthermore, at a trend level ARMS 376 
patient with a PSQI score >8 experienced increased negative symptoms compared 377 
to those endorsing a score of ≤ 8 on PSQI (Lunsford-Avery et al., 2017a). 378 
Poe et al. (2017) also reported negative symptoms to be associated with several 379 
SIPS measured sleep disturbances including daytime fatigue, sleep pattern 380 
disruption and day night reversal (B=3.12, p-value=0.02; B=4.48, p-value= < 0.01; 381 
and B=5.54, p-value= < 0.01, respectively). Furthermore, insomnia for two days was 382 
found to be related to negative symptoms at trend level.  383 
4.2.3 Sleep and functional outcomes 384 
Two studies reported on the relationship between sleep disruptions and functional 385 
outcomes (Lunsford-Avery et al., 2017a; Poe et al., 2017). Poe et al. (2017) revealed 386 
sleep pattern disruption assessed by the SIPS G1 subscale to be significantly 387 
associated with reduced GAF general functioning scores of ARMS youth.  388 
Furthermore, linear regression models revealed insomnia for two days to be related 389 
to role functioning and social functioning at trend level (Poe et al., 2017). In relation 390 
to psychosocial functioning as measured by the Global Assessment of Functioning 391 
(GAF), there were no significant difference between ARMS patients who scored ≤8 392 
or >8 on the PSQI (Lunsford-Avery et al., 2017a).   393 
 394 
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4.2.4 Sleep and Quality of Life 395 
In a sample of 160 ARMS patients, QoL assessed using the Manchester Short 396 
Assessment of Quality of Life scale was not found to be associated with sleep 397 
duration or sleep duration range measured by the Economic Patient Questionnaire 398 
interview. However, the authors acknowledged that the statistical tests may have 399 
been underpowered due to low completion rates of QoL measures (Reeve et al., 400 
2018a). 401 
4.3 Longitudinal relationship between sleep disturbances, psychotic 402 
symptoms, functioning and QoL 403 
4.3.1 Positive symptoms 404 
Six studies reported on sleep disturbances as a longitudinal predictor of positive 405 
psychotic symptoms and/or transition to psychosis (Lindgren et al., 2017b; Lunsford-406 
Avery et al., 2017b; Lunsford-Avery et al., 2015; Poe et al., 2017; Reeve et al., 407 
2018a; Ruhrmann et al., 2010). Reeve et al. (2018a) reported that shorter sleep 408 
duration (assessed using the Economic Patient Questionnaire Interview) predicted 409 
severity of delusional ideas (p=0.003) and hallucinations (p=0.01) across a 24 month 410 
follow up period. Delusional ideas remained significant even when controlling for 411 
sleep at the later time point (p= 0.036). However, when controlling for previous 412 
psychotic experience severity these results did not remain significant. Instead the 413 
strongest predictor for later psychotic experiences was the presence of previous 414 
psychotic experience rather than the occurrence of sleep disturbances.  In another 415 
study, ARMS patients wore actigraphs for five nights and findings revealed reduced 416 
sleep efficiency (F (4, 18) = 8.27, p < .01), lower total sleep time (F (4, 18) = 4.39, p 417 
< .05) and higher Wake After Sleep Onset (F (4, 18) = 4.94, p < .05) at baseline to 418 
be significantly related to positive symptoms at 12-month follow up (Lunsford-Avery 419 
et al., 2015). In a separate study involving the same sample, fragmented circadian rhythm 420 
(calculated using rest activity data derived from actigraphic measurements) at 421 
baseline correlated with positive symptoms at baseline and one year follow up 422 
(Lunsford-Avery et al., 2017b). Another longitudinal study reported no significant 423 
differences in the SIPS measured sleep disturbance scores of ARMS individuals with 424 
or without intentional self-harm at follow up (Lindgren et al., 2017a). 425 
    426 
Interestingly, sleep disturbances assessed by a SIPS score of >2 was included in a 427 
prediction model of transition to psychosis at 18-month follow up, in addition to five 428 
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other variables (including SIPS positive subscale scores) (Ruhrmann et al., 2010). 429 
The hazard ratio for sleep disturbances was 2.21 (95% confidence interval 1.034-430 
4.717); suggesting that conversion to psychosis in ARMS patients reporting SIPS 431 
sleep disturbance scores >2 was 2.21 times higher than those scoring <2 on the 432 
SIPS. On the contrary, a separate study conducted in the USA found that sleep 433 
items measured by the SIPS at baseline did not predict conversion to psychosis at 434 
2.5 year follow up (Poe et al., 2017). Furthermore, Grivel et al. (2018) reported that 435 
trauma history (TH) correlated with SIPS sleep disturbance scores, however TH was 436 
not found to be significantly related to conversions to psychosis at two year follow 437 
up. There were no further studies included in this review that reported sleep 438 
problems at baseline predicting transition to psychosis at follow up.    439 
4.3.2 Negative symptoms 440 
Two studies reported on the longitudinal relationship between sleep disruptions and 441 
negative symptoms (Lunsford-Avery et al., 2017b; Lunsford-Avery et al., 2015). Self-442 
reported PSQI disturbance scores and actigraphic variables at baseline were not 443 
significantly correlated with SIPS negative symptom levels at 12-month follow up 444 
(Lunsford-Avery et al., 2015). However, actigraphy measured diurnal activity 445 
(indicating the average activity level during the most active 10 hours of the day) 446 
predicted the severity of negative symptoms at 12 month follow up (Lunsford-Avery 447 
et al., 2017b).   448 
4.3.3 Functional outcomes 449 
One study revealed several actigraphic variables to predict functional outcome in 450 
ARMS patients. In this study, circadian rhythm variables (such as autocorrelation 451 
function which may be used to derive degree of rhythm fragmentation) at baseline 452 
were found to be related to psychosocial functioning levels measured by the Global 453 
Assessment of Functioning scale at one year follow up (Lunsford-Avery et al., 454 
2017b).  455 
4.3.4 Quality of Life 456 
None of the included studies provided findings on the longitudinal relationship 457 
between quality of life on sleep disturbances in ARMS youth. 458 
 459 
 460 
 461 
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Table 1. Details of included studies  462 
Author Year Country Study design  ARMS N 
(male/female) 
Comparator 
N 
(male/female
) 
ARMS 
Assess
ment 
Measur
e 
Sleep 
Instrument 
Functioning 
Assessment 
Measure 
Positive 
symptoms 
Assessment 
Measure 
Negative 
Symptoms 
Assessment 
Measure 
Quality 
Score 
(Down
s and 
Black, 
1998) 
Castro et al. 
(2015)† 
2015 Brazil Cross-sectional 
study 
20 At risk for 
psychosis/BD 
(13/7) 
20 Healthy 
Controls 
(13/7) 
CAARM
S 
Actigraphy, 
PSQI, 
ESS,QME 
NR NR NR 10 
Lederman et 
al. (2017) 
2017 Australia Cross-sectional 
study 
10 ARMS (8/2) 10 FEP (8/2); 
10 HC (7/3) 
CAARM
S 
PSQI NR NR NR 10 
Lunsford-
Avery et al. 
(2013)‡ 
2013 USA Cross-sectional 
study 
33 UHR (22/11) 33 Healthy 
Controls 
(14/19) 
SIPS PSQI NR SIPS SIPS 12 
Lunsford-
Avery et al. 
(2017a)‡ 
2017 USA Cross-sectional 
study 
62 UHR (37/25) none SIPS PSQI GAF SIPS SIPS 14 
Michels et al. 
(2014) 
2014 Germany Cross-sectional 
study 
14  UHR (9/5) 17 
Schizophreni
a (9/8). 17 
Healthy 
Relatives 
(7/10). 29 
Healthy 
Controls 
(18/11) 
Early 
Recognit
ion 
Inventor
y 
Lucid dream 
and 
nightmare 
frequency 
scales 
None 
reported 
Early 
Recognition 
Inventory 
Early 
Recognition 
Inventory 
11 
Tso et al. 
(2017) 
2017 USA Cross-sectional 
study 
203 CHR 
(115/88) 
87 CLR 
(61/26); 44 
EFEP (26/18) 
SOPS SOPS GFS  PANSS PANSS 15 
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Zanini et al. 
(2015)† 
2015 Brazil Cross-sectional 
study 
20 At risk for 
psychosis/BD 
(13/7) 
20 Healthy 
Controls 
(13/7) 
CAARM
S 
PSG, 
PSQI,ESS,Q
ME 
NR NR NR 11 
Miller et al. 
(2003b)¥ 
2003 USA & 
Canada 
RCT 60 UHR (39/21) None SIPS SIPS GAF PANSS PANSS 13 
Reeve et al. 
(2018a) 
2018 UK RCT 160 ARMS 
(98/62) 
None CAARM
S 
Economic 
Patient 
Questionnair
e Interview 
NR CAARMS NR 15 
Goines et al. 
(2019)¥ 
2019 USA & 
Canada 
Cohort Study 740 ARMS 
(424/316) 
280 Healthy 
Controls 
141/139) 
SIPS SIPS NR SIPS SIPS 15 
Grivel et al. 
(2018)  
2018 USA Cohort study 200 UHR 
(114/56) 
None SIPS SIPS GFS SIPS SIPS 11 
Lindgren et al. 
(2017b) 
2017 Finland Cohort Study 54 CHR (10/44) 107 non-
CHR (24/83) 
SIPS SIPS GFS SIPS SIPS 14 
Lunsford-
Avery et al. 
(2015) ‡ 
2015 USA Cohort Study 36 UHR (19/17) 31 Healthy 
Controls 
SIPS Actigraphy, 
PSQI 
NR SIPS SIPS 14 
Lunsford-
Avery et al. 
(2017b) ‡ 
2017 USA Cohort Study 34 UHR (15/19) 32 Healthy 
Controls 
(16/16) 
SIPS Actigraphy  GAF SIPS SIPS 13 
Poe et al. 
(2017)  
2017 USA Cohort study 194 UHR 
(142/52); 66 
Healthy Controls 
(42/24) 
None SIPS SIPS  GAF SIPS SIPS 13 
Ruhrmann et 
al. (2010)  
2010 Germany, 
Finland, 
the 
Netherland
s and 
Cohort study 245 UHR 
(137/108) 
None SIPS SIPS  GAF SIPS SIPS 16 
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England 
CAARMS: Comprehensive Assessment of the At Risk Mental State; SIPS/SOPS: Structured Interview for Prodromal Symptoms; PSG: Polysomnography; PSQI: Pittsburgh 463 
Sleep Quality Index; ESS: Epworth Sleepiness Scale; QME: Questionnaire of Morningness and Eveningness Scale;; PANSS: Positive and Negative Syndrome Scales; SOFAS 464 
Social and occupational functioning assessment scale; GAF: Global assessment of functioning; GFS: Global functioning scales; NR: Not reported; †study produced by the 465 
Program for Recognition and Intervention in Individuals at-risk Mental State; ‡ study produced by the Adolescent Development and Prevention Treatment lab; ¥ Data taken 466 
from the North American Prodrome Longitudinal Study; ≠Downs and Black Quality score: excellent (26-28), good (20-25), fair (15-19) and poor (≤14)467 
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4.4 Exploratory meta-analysis examining self-reported sleep disturbances in 468 
ARMS youth 469 
A comparison between ARMS patients and controls in relation to self-reported sleep 470 
disturbances measured by the SIPS was found to be significantly different (see 471 
figure 2). The mean difference in score was 1.58 (95% CI 0.80, 2.35) z=4.00, 472 
p<0.00001. In the studies by Poe et al. (2017) and Goines et al. (2019) the sleep 473 
disturbances of ARMS patients was compared to healthy controls. In the study by 474 
Tso et al. (2017) the sleep disturbance scores of ‘clinically higher risk’ individuals 475 
with a score ≥7 on SOPS were compared to ‘clinically lower risk’ participants, or 476 
those scoring <7 on the SOPS. All participants were help seeking in this sample. The 477 
clinical diversity between the control groups may explain the high I2 value (I2=95%). 478 
The mean difference in score remained significant when the study by Tso et al. 479 
(2017) was excluded from the analysis; mean difference in score was 2.04 (95% CI 480 
1.58, 2.49) z=8.73, p<0.00001 (I2=83%). 481 
Figure 2. Sleep disturbance (SIPS) 482 
 483 
Two studies were included in the meta-analysis for sleep disturbances measured 484 
using the PSQI (see figure 3) (Lederman et al., 2017; Zanini et al., 2015). The ARMS 485 
group and healthy controls differed significantly and there was no significant 486 
heterogeneity between the studies. The mean difference in score was 3.30 (95% CI 487 
1.87, 4.74) z=4.50, p<0.00001, suggesting that at-risk youth experienced 488 
significantly higher levels of sleep disturbances compared to healthy controls. 489 
Figure 3. Sleep disturbance (PSQI) 490 
 491 
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4.5 Risk of bias assessment 492 
Quality scores are summarised in table 1. Overall scores were heavily influenced by 493 
study design; for instance observational studies scored lower on questions relating to 494 
internal validity bias (e.g. studies that did not include a comparator group could not 495 
receive points on questions relating to selection bias). Several studies did not include 496 
follow up assessments which impacted on the risk of bias scores. All studies 497 
generally reported insufficient information on power calculations. Grey literature 498 
including doctoral thesis and conference abstracts were screened for eligibility. 499 
However, participants in these studies did not fulfil the UHR criteria and 500 
consequently were not included in this review.  The majority of studies included were 501 
considered to be low quality according to the Downs and Black checklist. 502 
Table 2. Definition of sleep terms 503 
Sleep terms Definition 
Sleep Latency The amount of time it takes to transition from wakefulness into a state of 
sleep or NREM stage 1 sleep 
Sleep Efficiency The amount of time spent asleep compared to the total time spent trying to 
fall asleep; also calculated as the ratio of total sleep time (TST) to time 
spent in bed (TIB)  
Sleep Duration The length of time spent asleep 
Wake After Sleep 
Onset (WASO) 
Time spent awake after defined sleep onset. Can indicate fragmented sleep 
Insomnia A sleep disorder characterised by difficulties falling and/or staying asleep 
Rapid Eye Movement 
(REM) 
A state of sleep usually occurring during a normal sleep cycle characterised 
by raised activity in the forebrain and midbrain neuronal regions, in addition 
to reduced muscle tone. Dreaming and rapid eye movements typically take 
place during this state of sleep 
Non Rapid Eye 
Movement (NREM) 
A state of sleep (also called non-REM or slow wave sleep) usually occurring 
during a typical sleep cycle characterised by delta waves and reduced levels 
of physiological activity 
Circadian Rhythms Internal biological rhythms that that coordinate behavioural and physical 
activity with the environment during a twenty four hour period. The circadian 
rhythm regulate the sleep wake cycle 
Parasomnias  Sleep disorders characterised by abnormal behaviours during any stage of 
sleep such as sleep walking, sleep related eating 
Actigraph A non-intrusive device worn to monitor and record movement/activity levels 
and light exposure. The data can be used in conjunction with a sleep diary 
to understand  rest/activity cycles. Actigraph’s are usually worn on the wrist 
or ankle over a period of a week or more 
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Polysomnography 
(PSG) 
PSG is the gold standard assessment of sleep which involves recording 
brain activity through EEG and monitoring bodily functions (including eye 
movement, breathing rhythms, heart rate, respiratory data, muscle activity) 
during sleep 
Sleep spindle Electrical brain activity measuring 7 to 14 Hz lasting for 1 to 2 seconds 
typically observed in sleep stage 2. 
Sleep stage There are three distinct stages of sleep which humans cycle between during 
a sleep period. Stage 1 is NREM sleep is recognised on EEG by low 
voltage, missed frequency waves with small eye movements. Stage 2 is the 
second stage of NREM sleep characterised by sleep spindles and K-
complexes. Stage 3 is NREM sleep identified by high voltage, slow wave 
activity tonic muscles and no eye movements.  
 504 
5 DISCUSSION  505 
5.1 Summary of findings 506 
This review builds on previous research examining the significance of sleep 507 
disturbances in psychotic illness, through highlighting that sleep disruptions are 508 
present in at risk for psychosis groups and that they are associated with psychotic 509 
symptoms and functional outcomes. A strength of this review is the inclusion of the 510 
exploratory meta-analysis which revealed poorer global sleep quality amongst ARMS 511 
patients. 512 
5.2 Self-report and objective sleep disturbances in ARMS patients 513 
This review has highlighted that ARMS patients report higher levels of general sleep 514 
disturbances, increased night time disruption, and increased nightmares. However, 515 
sleep efficiency and duration were not reported to be reduced in ARMS groups. 516 
These findings are important as they demonstrate distinctions in self-reported sleep 517 
problems among ARMS youth. The meta-analyses results show that global self-518 
reported sleep quality is significantly reduced in ARMS and these disruptions are 519 
detectable by both the PSQI and the SIPS clinical assessment tool. Interestingly, the 520 
PSQI global scores of the ARMS samples are comparable to those seen in other 521 
clinical groups (e.g. cut off score of 5 for students; >6 for adults with back pain; ≥8 for 522 
adults with TBI) (Mollayeva et al., 2016). Therefore, these measures can be 523 
considered appropriate for the assessment of global sleep disruptions in ARMS 524 
patients. However, as has been highlighted in research involving schizophrenia 525 
patients (Faulkner and Sidey-Gibbons, 2019) it is important to establish the utility 526 
23 
 
and cut-off scores of self-reported sleep tools such as the PSQI and SIPS in ARMS 527 
youth.  528 
Several objectively assessed parameters of sleep were found to be disrupted in 529 
ARMS youth including quantity of sleep (e.g., PSG latency, daytime naps and night 530 
time movements) and circadian rhythm. However, sleep efficiency, duration and 531 
night time awakenings were not found to be significantly reduced in ARMS patients 532 
compared to controls. These findings should be interpreted with caution as a small 533 
number of included studies (n=4) used PSG or actigraphy to assess sleep 534 
disturbances. It is important to acknowledge the significant challenges associated 535 
with conducting sleep studies, therefore exploration of the macro and micro 536 
architecture of sleep in such a limited number of studies provides significant gains in 537 
knowledge.  538 
5.3 Cross-sectional associations between sleep disruptions and the ARMS  539 
This review has reported several sleep parameters (e.g., reduced sleep efficiency, 540 
increased WASO, increased night time awakening and movements) to be associated 541 
with positive psychotic symptoms. Conversely, increased latency, duration and 542 
quality were reported to be related to negative symptoms. These findings 543 
complement previous research focused on patients with psychotic disorder 544 
(Blanchard et al., 2020; Reeve et al., 2015) as they show that a relationship between 545 
attenuated psychotic symptoms and sleep disturbances is present prior to diagnosis 546 
of psychotic disorder. The interaction between sleep impairments and negative 547 
symptoms is a particularly interesting and under researched area in ARMS patients. 548 
The timing of the psychosis prodrome may coincide with a period whereby negative 549 
symptoms and sleep problems may be entangled with social and developmental 550 
changes. Consequently, it is crucial that our knowledge around the relationship 551 
between sleeping difficulties and negative symptoms is developed to support early 552 
detection of such phenomena in adolescents and young adults. 553 
5.4 Longitudinal relationship between sleep disruptions and the ARMS  554 
The findings from longitudinal studies highlight the relationship between disrupted 555 
sleep quality (e.g., sleep efficiency), quantity of sleep (e.g., Wake After Sleep Onset, 556 
number of awakenings, total sleep time) the rhythm of sleep/rest activity levels (e.g. 557 
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fragmented circadian rhythm, sleep pattern disruption and day night reversal) and 558 
increased positive symptoms across time. These findings can be explained by the 559 
concept of shared mechanisms underlying circadian misalignment and dysfunctional 560 
neurotransmitter systems thought to be implicated in the expression of schizophrenia 561 
and circadian pathways (Wulff et al., 2012).  Alternatively, the complex-generic and 562 
environmental model of mental disorders provides a developmental explanation for 563 
the comorbidities between sleep disruptions and mental health disorders. It suggests 564 
that early sleep disturbances resulting from pre-natal/ early life stress impact on the 565 
regulation of the HPA axis and stress system, mediated by epigenetic factors, which 566 
increases the risk of developing stress related disorders in adulthood (Palagini et al., 567 
2019). Other conceptual models and pathways have also been described in the 568 
literature, involving markers of oxidative stress in the brain (e.g. protein oxidation and 569 
lipid peroxidation), neuroprogression (e.g. hippocampal function), inflammatory 570 
molecules (e.g. cytokines) and disruptions to the HPA axis (Lopresti et al., 2013; 571 
Pandi-Perumal and Kramer, 2010).  It is therefore clear that the pathways and 572 
mediating factors implicated in the development of dysfunctional sleep and mental 573 
illness are complex, this review calls for further experimental studies investigating 574 
pathways involved in sleep dysfunction and psychopathology.” 575 
Understanding whether sleep disturbances represent the emergence of long-term 576 
sleep difficulties or a sleep disorder in ARMS patients is another important line of 577 
enquiry; particularly as research has shown that ARMS youth experience outcomes 578 
which are broader than transition to psychosis such as functional impairment 579 
(Addington et al., 2011; Carrión et al., 2013). Therefore, increased understanding of 580 
the trajectory of ARMS youth, not just in relation to mental health outcomes but also 581 
other long-term difficulties such as sleep disorders are essential when considering 582 
appropriate treatments and the priorities of sleep interventions in clinical practice 583 
(Cosgrave et al., 2018; Freeman et al., 2017; Ohayon, 1997; Reeve et al., 2018b). 584 
5.5 Sleep disruptions, functional outcomes and QoL in ARMS patients 585 
Few studies included in this review presented evidence on the relationship between 586 
sleep disturbances and functional outcomes during the ARMS period. Those that did 587 
reported on correlations between sleep pattern disruption and general functioning; in 588 
addition to circadian rhythm variables predicting long term psychosocial functioning 589 
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levels. These findings support previous research suggesting that sleep difficulties are 590 
related to reduced functioning in schizophrenia spectrum disorders and that 591 
improving sleep could improve functional outcomes, independent of other treatments 592 
(Laskemoen et al., 2019).  593 
It is also a surprising finding from this review that only one study reported on the 594 
cross-sectional association between sleep disturbances and QoL in an at risk 595 
sample, with no significant findings reported. This is unexpected as poor sleep has 596 
been implicated in sustaining reduced QoL and difficulties in coping (Hofstetter et al., 597 
2005). Furthermore, the profound impact of sleep and circadian rhythm disruptions 598 
on QoL and employability are both understudied and of high importance (Hofstetter 599 
et al., 2005; Yates, 2016). Adopting a holistic approach to care, which treats clinical 600 
symptoms whilst also prioritising improving QoL and functioning is invaluable to 601 
many individuals experiencing mental health problems (Katshnig 2006; 602 
Sagayadevan 2018). Therefore, there is a need for research which includes well 603 
defined and carefully measured QoL domains, in addition to exploration of distinct 604 
differences between direct and indirect impacts of sleep on QoL in ARMS youth.   605 
5.6 Strengths and limitations 606 
The review must be interpreted in light of the following limitations. Studies included in 607 
this review were highly heterogeneous in relation to the methodological 608 
characteristics, reflecting the broad understanding of sleep in ARMS individuals and 609 
the diversity in how sleep is measured. Furthermore, the reporting of descriptive 610 
statistics (e.g. means and standard deviations) was not consistently stated across 611 
studies. The consequence of this limitation was evident in the quantitative synthesis 612 
and meta-analysis whereby both meta-analyses only included two or three studies, 613 
resulting in an inability to conduct subgroup analyses. The small sample sizes in the 614 
meta-analysis and the heterogeneity of comparison groups are likely contributors of 615 
the wide confidence intervals and high I statistic (see figure 2). Although this reduces 616 
the generalisability of the findings, the meta-analyses results are exploratory and 617 
hypothesis generating rather than conclusive. Therefore, the findings from this 618 
review provide some advances in knowledge in this area. 619 
A second limitation is the unquestionable challenge of ascertaining the direction of 620 
causality between sleep disturbances and psychotic illness. There is a need for 621 
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further prospective studies which repeatedly assess sleep disturbances using robust 622 
self-report and objective tools, assessments of mental health status and related 623 
variables including premorbid functioning, personality characteristics, life events and 624 
symptoms (Mason et al., 2004). This would also provide an important opportunity for 625 
examining the putative role of sleep disruptions in the development and full 626 
manifestation of psychosis. 627 
A third limitation is the quality of studies included according to the Downs and Black 628 
quality index tool. The majority of studies were assessed to be low quality (12/16) 629 
and scores were largely influenced by study design. Consequently, further high 630 
quality research is needed to better assess the relationship between sleep 631 
disturbances and the at risk mental state.  632 
5.7 Clinical and research implications 633 
Research has shown that clinicians in mental health teams often assess sleep 634 
problems informally, with no treatment offered or basic sleep hygiene and/or 635 
pharmacology rather than recommended CBT treatments for individuals with 636 
persistent insomnia (O'Sullivan et al., 2015; Rehman et al., 2017). Sleep problems 637 
are often seen as secondary or corollary to the psychiatric symptoms and therefore 638 
not given adequate focus. Treatment for sleep problems are often limited by service 639 
level challenges (such as lack of time and training), patient factors (including 640 
lifestyle) and environmental issues (e.g. inpatient settings). Given the effectiveness 641 
of psychological treatments such as Cognitive Behavioural Therapy for Insomnia 642 
(Bradley et al., 2018; Freeman et al., 2017; Myers et al., 2011) and the impact of 643 
sleep disturbances on psychopathology and functioning, there is a strong need to 644 
recognise and treat sleep disturbance using effective and inexpensive interventions, 645 
early in the course of mental illness (Harvey et al., 2011). 646 
The findings from this review also have important implications for future research. It 647 
is evident that the relationship between sleep disturbances and early symptoms is 648 
complex and the mechanisms and mediating factors between these experiences are 649 
yet to be fully understood. Further research examining disruptions to sleep 650 
architecture (e.g., sleep spindles defined as electrical brain activity typically observed 651 
in stage 2 sleep) in ARMS patients is key, particularly as research has suggested 652 
that they are implicated in reasoning, attention and memory consolidation in 653 
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schizophrenia patients (Ferrarelli et al., 2007; Göder et al., 2015; Keshavan et al., 654 
2011a; Manoach et al., 2014; Manoach et al., 2016; Poulin et al., 2003; Wamsley et 655 
al., 2012) and that spindles and slow waves may be valid biomarkers for 656 
schizophrenia (Zhang et al., 2019). There is a need for further high-quality 657 
experimental studies utilising well-powered, accurate and practical methods  658 
involving early course psychosis patients to explore the structure of sleep. For 659 
instance, recent research has shown afternoon naps to be correlated with nocturnal 660 
spindle density in schizophrenia patients; highlighting an alternative method for 661 
assessing the spectral content of sleep (Mylonas et al., 2019). 662 
6 CONCLUSIONS  663 
Our review suggests that young people at risk for psychosis experience increased 664 
levels of self-reported and objectively measured sleep disturbances compared to 665 
healthy controls, including poorer global sleep quality (as measured by the PSQI and 666 
SIPS). Furthermore, there is evidence that sleep disturbances at baseline are 667 
associated with higher levels of positive psychotic symptoms over time. However, 668 
due to the limited number of longitudinal studies in this area, further research is 669 
needed to build our understanding of how much sleep disturbances during the at risk 670 
period worsen or contribute to increased psychotic symptoms at later time points. 671 
This is key for establishing the relative importance of services prioritising sleep 672 
disturbance treatments in ARMS patients. 673 
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